BioCryst Pharmaceuticals | BCRX - Interest Income


BioCryst Pharmaceuticals reported $-0.13 in Interest Income for its fiscal quarter ending in December of 2024.





Interest Income Change Date
Alnylam Pharmaceuticals USD 26.6M 32K Mar/2026
BioCryst Pharmaceuticals USD -0.13 3.59M Dec/2024
Chugai Pharma JPY 480M 465M Jun/2024
Daiichi Sankyo JPY 9.96B 230M Mar/2024
DBV Technologies USD -0.32 0.02 Sep/2024
Gilead Sciences USD 95M 0 Mar/2026
GlaxoSmithKline GBP 22M 96M Mar/2026
Glaxosmithkline GBP 22M 4M Mar/2026
Incyte USD 38.12M 4.43M Jun/2026
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
Karyopharm Therapeutics USD -0.15 0.11 Dec/2024
Novavax USD 303K 27K Dec/2021
Regeneron Pharmaceuticals USD 183.3M 200K Jun/2026
Sarepta Therapeutics USD 7M 1.74M Mar/2026
Ultragenyx Pharmaceutical USD 6M 512K Mar/2026
Vertex Pharmaceuticals USD 120.6M 5.8M Jun/2026